Epicor Medical Inc.

Obstructive sleep apnea (OSA) is a common, devastating and costly condition. It affects an estimated 100 million people worldwide, of whom 18 million are in the US alone, and its societal costs are hu

Most current cardiac diagnostic imaging tests are highly inexact, relying heavily on clinicians' observations. HeartFlow is adapting advanced computer modeling to cardiology to produce a precise, pred

by Mary Thompson Tremendous progress has been made in the field of ablation therapy for atrial fibrillation (AF) over the past several years, and numerous device-based technologies to address this und

Hoping to succeed in the elusive field of AF, Endosense is taking an anti-start-up strategy: focusing more on later-stage commercialization and market launch and less on technology vetting. By David C